Growth, growth factors and diabetes

European Journal of Endocrinology, Supplement

Volumn 151, Issue 3, 2004, Pages

  Chiarelli, Francesco ^a,b   Giannini, Cosimo ^a   Mohn, Angelika ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b Policlinico   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; GROWTH HORMONE; SOMATOMEDIN C;

ADOLESCENT; BODY GROWTH; BODY HEIGHT; CHILD; CHILD GROWTH; CHRONIC DISEASE; CONFERENCE PAPER; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GROWTH ACCELERATION; HORMONAL REGULATION; HUMAN; INSULIN BLOOD LEVEL; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; REGULATORY MECHANISM; SHORT STATURE;

ADOLESCENT; BLOOD GLUCOSE; BODY HEIGHT; CHILD; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; GROWTH DISORDERS; GROWTH HORMONE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; PUBERTY;

EID: 10344247625     PISSN: 08044635     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (95)

1. Guest CM. The Mauriac syndrome: dwarfism, hepatomegaly and obesity with juvenile diabetes mellitus. Diabetes 1953 2 415-417.
2. Salardi S, Tonioli S, Tassoni P, Tellarini M, Mazzanti L & Cacciari E. Growth and growth factors in diabetes mellitus. Archives of Diseases in Childhood 1987 62 57-62.
3. Penfold J, Chase HP, Marshall G, Walravens CF, Walravens PA & Garg SK. Final adult height and its relationship to blood glucose control and microvascular complications in IDDM. Diabetic Medicine 1995 12 129-133.
4. Donaghue KC, Kordonouri O, Chan A & Silink M. Secular trends in growth in diabetes: are we winning? Archives of Diseases in Childhood 2003 88 151-154.
5. Kember NF. Cell kinetics and the control of growth in long bones. Cell Tissue Kinetics 1978 11 477-485.
6. Kember NF. Cell kinetics and the control of bone growth. Acta Paediatrica 1993 82 (Suppl 391) 61-65.
7. Salmon WD Jr & Daughaday WH. A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. Journal of Laboratory and Clinical Medicine 1957 49 825-836.
8. Salmon WD Jr & Daughaday WH. A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. Journal of Laboratory and Clinical Medicine 1990 116 408-419.
9. Jones JI & Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocrine Reviews 1995 16 3-34.
10. Blum W & Ranke MB. Insulin-like growth factor binding proteins (IGFBPs) with special reference to IGFBP-3. Acta Paediatrica Scandinavica 1990 (Suppl 367) 55-62.
11. Hwa V, Oh Y & Rosenfeld RG. The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocrine Reviews 1999 20 761-787.
12. Baxter RC & Turtle JR. Regulation of hepatic growth hormone receptors by insulin. Biochemical and Biophysical Research Communications 1978 84 350-357.
13. Daughaday WH, Phillips LS & Mueller MC. The effects of insulin and growth hormone on the release of somatomedin by the isolated rat liver. Endocrinology 1976 98 1214-1219.
14. Maes M, Underwood LE & Ketelslegers JM. Low serum somatomedin-C in insulin-dependent diabetes: evidence for a postreceptor mechanism. Endocrinology 1986 118 377-382.
15. Cotterill AM. Cowell CT & Silink M. Insulin and variation in glucose levels modify the secretion rates of the growth hormone-independent insulin-like growth factor binding protein-1 in the human hepatoblastoma cell line Hep G2. Journal of Endocrinology 1989 12 R17-R20.
16. Holly JM, Biddlecombe RA, Dunger DB, Edge JA, Amiel SA, Howell R, Chard T, Rees LH & Wass JA. Circadian variation of GH-independent IGF-binding protein in diabetes mellitus and its relationship to insulin. A new role for insulin? Clinical Endocrinology 1988 29 667-675.
17. Holly JM, Dunger DB, Edge JA, Smith CP, Chard T & Wass JA. Insulin-like growth factor binding protein-1 levels in diabetic adolescents and their relationship to metabolic control. Diabetic Medicine 1990 7 618-623.
18. Dunger DB & Cheetham TD. Growth hormone-insulin-like growth factor-I axis in insulin-dependent diabetes mellitus. Hormone Research 1996 46 2-6.
19. Holl RW, Siegler B, Scherbaum WA & Heinze E. The serum growth hormone-binding protein is reduced in young patients with insulin-dependent diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 1993 76 165-167.
20. Menon RK, Arslanian S, May B, Cutfield WS & Sperling MA. Diminished growth hormone-binding protein in children with insulin-dependent diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 1992 74 934-938.
21. Arslanian SA, Menon RK, Gierl AP, Heil BV & Foley TP Jr. Insulin therapy increases low plasma growth hormone binding protein in children with new-onset type 1 diabetes. Diabetic Medicine 1993 10 833-838.
22. Yakar S, Setser J, Zhao H, Stannard B, Haluzik M, Glatt V, Bouxsein ML, Kopchick JJ & LeRoith D. Inhibition of growth hormone action improves insulin sensitivity in liver IGF-I-deficient mice. Journal of Clinical Investigation 2004 113 96-105.
23. Fowelin J, Attvall S, von Schenck H, Smith U & Lager I. Characterization of the insulin-antagonistic effect of growth hormone in man. Diabetologia 1991 34 500-506.
24. Davidson MB. Effect of growth hormone on carbohydrate and lipid metabolism. Endocrine Reviews 1987 8 115-131.
25. Rizza RA, Mandarino LJ & Gerich JE. Effects of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization. Diabetes 1982 31 663-669.
26. Bratusch-Marrain PR, Smith D & DeFronzo RA. The effect of growth hormone on glucose metabolism and insulin secretion in man. Journal of Clinical Endocrinology and Metabolism 1982 55 973-982.
27. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC & Palmer JP. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 1993 42 1663-1672.
28. Acerini CL, Cheetham TD, Edge JA & Dunger DB. Both insulin sensitivity and insulin clearance in children and young adults with Type I (insulin-dependent) diabetes vary with growth hormone concentrations and with age. Diabetologia 2000 43 61-68.
29. Edge JA, Matthews DR & Dunger DB. The dawn phenomenon is related to overnight growth hormone release in adolescent diabetics. Clinical Endocrinology 1990 33 729-737.
30. Thirone AC, Carvalho CR & Saad MJ. Growth hormone stimulates the tyrosine kinase activity of JAK2 and induces tyrosine phosphorylation of insulin receptor substrates and Shc in rat tissues. Endocrinology 1999 140 55-62.
31. VanderKuur J, Allevato G, Billestrup N, Norstedt G & Carter-Su C. Growth hormone-promoted tyrosyl phosphorylation of SHC proteins and SHC association with Grb2. Journal of Biological Chemistry 1995 270 7587-7593.
32. Vanderkuur JA, Butch ER, Waters SB, Pessin JE, Guan KL & Carter-Su C. Signaling molecules involved in coupling growth hormone receptor to mitogen-activated protein kinase activation. Endocrinology 1997 138 4301-4307.
33. Kilgour E, Gout I & Anderson NG. Requirement for phosphoinositide 3-OH kinase in growth hormone signalling to the mitogen-activated protein kinase and p70s6k pathways. Biochemical Journal 1996 315 517-522.
34. Argetsinger LS, Hsu GW, Myers MG Jr, Billestrup N, White MF & Carter-Su C. Growth hormone, interferon-gamma, and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1. Journal of Biological Chemistry 1995 270 14685-14692.
35. Argetsinger LS, Norstedt G, Billestrup N, White MF & Carter-Su C. Growth hormone, interferon-gamma, and leukemia inhibitory factor utilize insulin receptor substrate-2 in intracellular signaling. Journal of Biological Chemistry 1996 271 29415-29421.
36. Adams TE. Adams TE. Hansen JA. Starr R. Nicola NA. Hilton DJ & Billestrup N. Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling. Journal of Biological Chemistry 1998 273 1285-1287.
37. Mooney RA, Senn J, Cameron S, Inamdar N, Boivin LM, Shang Y & Furlanetto RW. Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor. A potential mechanism for cytokine-mediated insulin resistance. Journal of Biological Chemistry 2001 276 25889-25893.
38. Peraldi P, Filloux C, Emanuelli B, Hilton DJ & Van Obberghen E. Insulin induces suppressor of cytokine signaling-3 tyrosine phosphorylation through Janus-activated kinase. Journal of Biological Chemistry 2001 276 24614-24620.
39. Dey BR, Furlanetto RW & Nissley P. Suppressor of cytokine signaling (SOCS)-3 protein interacts with the insulin-like growth factor-I receptor. Biochemical and Biophysical Research Communications 2000 278 38-43.
40. Emanuelli B, Peraldi P, Filloux C, Sawka-Verhelle D, Hilton D & Van Obberghen E. SOCS-3 is an insulin-induced negative regulator of insulin signaling. Journal of Biological Chemistry 2000 275 15985-15991.
41. Rui L, Yuan M, Frantz D, Shoelson S & White MF. SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. Journal of Biological Chemistry 2002 277 42394-42398.
42. Kawazoe Y, Naka T, Fujimoto M, Kohzaki H, Morita Y, Narazaki M, Okumura K, Saitoh H, Nakagawa R, Uchiyama Y, Akira S & Kishimoto T. Signal transducer and activator of transcription (STAT)-induced STAT inhibitor 1 (SSI-1)/suppressor of cytokine signaling 1 (SOCS1) inhibits insulin signal transduction pathway through modulating insulin receptor substrate 1 (IRS-1) phosphorylation. Journal of Experimental Medicine 2001 193 263-269.
43. Chiarelli F, Santilli F & Mohn A. Role of growth factors in the development of diabetic complications. Hormone Research 2000 53 53-67.
44. Quattrin T, Thrailkill K, Baker L, Kuntze J, Compton P & Martha P. Improvement of HbAlc without increased hypoglycemia in adolescents and young adults with type 1 diabetes mellitus treated with recombinant human insulin-like growth factor-I and insulin. rhIGF-I in IDDM Study Group. Journal of Pediatric Endocrinology and Metabolism 2001 14 267-277.
45. Thrailkill K, Quattrin T, Baker L, Litton J, Dwigun K, Rearson M, Poppenheimer M, Kotlovker D, Giltinan D, Gesundheit N & Martha P Jr. Dual hormonal replacement therapy with insulin and recombinant human insulin-like growth factor (IGF)-I in insulin-dependent diabetes mellitus: effects on the growth hormone/IGF/IGF-binding protein system. Journal of Clinical Endocrinology and Metabolism 1997 82 1181-1187.
46. Acerini CL & Dunger DB. Insulin-like growth factor-I for the treatment of type 1 diabetes. Diabetes, Obesity and Metabolism 2000 2 335-343.
47. Crowne EC, Samra JS, Cheetham T, Acerini CL, Watts A, Holly JM & Dunger DB. The role of IGF-binding proteins in mediating the effects of recombinant human IGF-I on insulin requirements in type 1 diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 2001 86 3686-3691.
48. Smith LE, Shen W, Perruzzi C, Soker S, Kinose F, Xu X, Robinson G, Driver S, Bischoff J, Zhang B, Schaeffer JM & Senger DR. Regulation of vascular endothelial growth factor dependent retinal neovascularization by insulin like growth factor 1 receptor. Nature Medicine 1999 5 1390-1395.
49. Kondo T, Vicent D, Suzuma K, Yanagisawa M, King GL, Holzenberger M & Kahn CR. Knockout of insulin and IGF-I receptors on vascular endothelial cells protects against retinal neovascularization. Journal of Clinical Investigation 2003 111 1835-1842.
50. Verrotti A, Cieri F, Petitti MT, Morgese G & Chiarelli F. Growth hormone and IGF-I in diabetic children with and without microalbuminuria. Diabetes, Nutrition and Metabolism 1999 12 271-276.
51. Chiarelli F, Spagnoli A, Basciani F, Tumini S, Mezzetti A, Cipollone F, Cuccurullo F, Morgese G & Verrotti A. Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with type 1 diabetes mellitus: relation to glycaemic control and microvascular complications. Diabetic Medicine 2000 17 650-656.
52. Santilli F, Spagnoli A, Mohn A, Tumini S, Verrotti A, Cipollone F, Mezzetti A & Chiarelli F. Increased vascular endothelial growth factor serum concentrations may help to identify patients with onset of type 1 diabetes during childhood at risk for developing persistent microalbuminuria. Journal of Clinical Endocrinology and Metabolism 2001 86 3871-3876.
53. Price DE & Burden AC. Growth of children before onset of diabetes. Diabetes Care 1992 15 1393-1395.
54. Drayer NM. Height of diabetic children at onset of symptoms. Archives of Diseases in Childhood 1974 49 616-620.
55. Edelsten AD, Hughes IA, Oakes S, Gordon IR & Savage DC. Height and skeletal maturity in children with newly-diagnosed juvenile-onset diabetes. Archives of Diseases in Childhood 1981 56 40-44.
56. Bognetti E, Riva MC, Bonfanti R, Meschi F, Viscardi M & Chiumello G. Growth changes in children and adolescents with short-term diabetes. Diabetes Care 1998 21 1226-1229.
57. Wise JE, Kolb EL & Sauder SE. Effect of glycemic control on growth velocity in children with IDDM. Diabetes Care 1992 15 826-830.
58. Holl RW, Heinze E, Seifert M, Grabert M & Teller WM. Longitudinal analysis of somatic development in paediatric patients with IDDM: genetic influences on height and weight. Diabetologia 1994 37 925-929.
59. Cianfarani S, Bonfanti R, Manca Bitti ML, Germani S, Boemi S, Chiumello G & Boscherini B. Growth and insulin-like growth factors in children with insulin-dependent diabetes mellitus at the onset of disease: evidence for normal growth, age dependency of the IGF system alterations, and presence of a small (approximately 18-kilodalton) IGF-binding protein-3 fragment in serum. Journal of Clinical Endocrinology and Metabolism 2000 85 4162-4167.
60. Du Caju MV, Rooman RP & op de Beeck L. Longitudinal data on growth and final height in diabetic children. Pediatric Research 1995 38 607-611.
61. Brown M, Ahmed ML, Clayton KL & Dunger DB. Growth during childhood and final height in type 1 diabetes. Diabetic Medicine 1994 11 182-187.
62. Songer TJ, LaPorte RE, Tajima N, Orchard TJ, Rabin BS, Eberhardt MS, Dorman JS, Cruickshanks KJ, Cavender DE & Becker DJ. Height at diagnosis of insulin-dependent diabetes in patients and their non-diabetic family members. British Medical Journal 1986 292 1419-1422.
63. Thon A, Heinze E, Feilen KD, Holl RW, Schmidt H, Koletzko S, Wendel U & Nothjunge J. Development of height and weight in children with diabetes mellitus: report on two prospective multicentre studies, one cross-sectional, one longitudinal. European Journal of Pediatrics 1992 151 258-262.
64. Gunczler P, Lanes R, Esaa S & Paoli M. Effect of glycemic control on the growth velocity and several metabolic parameters of conventionally treated children with insulin-dependent diabetes mellitus. Journal of Pediatric Endocrinology and Metabolism 1996 9 569-575.
65. Knip M, Tapanainen P, Pekonen F & Blum WF. Insulin-like growth factor binding proteins in prepubertal children with insulin-dependent diabetes mellitus. European Journal of Endocrinology 1995 133 440-444.
66. Tapanainen P, Kaar ML, Leppaluoto J, Huttunen NP & Knip M. Normal stimulated growth hormone secretion but low peripheral levels of insulin-like growth factor I in prepubertal children with insulin-dependent diabetes mellitus. Acta Paediatrica 1995 84 646-650.
67. Munoz MT, Barrios V, Pozo J & Argente J. Insulin-like growth factor I, its binding proteins 1 and 3, and growth hormone-binding protein in children and adolescents with insulin-dependent diabetes mellitus: clinical implications. Pediatric Research 1996: 39 992-998.
68. Taylor AM, Dunger DB, Grant DB & Preece MA. Somatomedin-C/IGF-I measured by radioimmunoassay and somatomedin bioactivity in adolescents with insulin-dependent diabetes compared with puberty matched controls. Diabetes Research 1988 9 177-181.
69. Rogers DG, Sherman LD & Gabbay KH. Effect of puberty on insulin-like growth factor I and HbAlc in type 1 diabetes. Diabetes Care 1991 14 1031-1035.
70. Dills DG, Allen C, Palta M, Zaccaro DJ, Klein R & D'Alessio D. Insulin-like growth factor-I is related to glycemic control in children and adolescents with newly diagnosed insulin-dependent diabetes. Journal of Clinical Endocrinology and Metabolism 1995 80 2139-2143.
71. Bereket A, Lang CH, Blethen SL, Ng LC & Wilson TA. Insulin treatment normalizes reduced free insulin-like growth factor-I concentrations in diabetic children. Clinical Endocrinology 1996 45 321-326.
72. Amiel SA, Sherwin RS, Hintz RL, Gertner JM, Press CM & Tamborlane WV. Effect of diabetes and its control on insulin-like growth factors in the young subject with type I diabetes. Diabetes 1984 33 1175-1179.
73. Rudolf MCJ, Sherwin RS, Markowitz R, Bates SE, Genel M, Hochstadt J & Tamborlane WV. Effect of intensive insulin treatment on linear growth in the young diabetic patients. Journal of Pediatrics 1982 101 333-339.
74. Clark PA, Clarke WL, Pedadda S, Reiss A, Langlois C, Nieves-Rivera F & Rogol AD. The effects of pubertal status and glycemic control on the growth hormone-IGF-I axis in boys with insulin-dependent diabetes mellitus. Journal of Pediatric Endocrinology and Metabolism 1998 11 427-435.
75. Batch JA, Baxter RC & Werther G. Abnormal regulation of insulin-like growth factor binding proteins in adolescents with insulin-dependent diabetes. Journal of Clinical Endocrinology and Metabolism 1991 73 964-968.
76. Cinaz P, Kendirci M, Kurtoglu S, Gokcora N, Buyan N, Yavuz I & Demir A. Serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in children with insulin-dependent diabetes mellitus. Journal of Pediatric Endocrinology and Metabolism 1996 9 475-482.
77. Amiel SA, Sherwin RS, Simonson DC, Lauritano AA & Tamborlane WV. Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes. New England Journal of Medicine 1986 315 215-219.
78. Bloch CA, Clemons P & Sperling MA. Puberty decreases insulin sensitivity. Journal of Pediatrics 1987 110 481-487.
79. Scottish Study Group for the Care of the Young Diabetic. Factors influencing glycemic control in young people with type 1 diabetes in Scotland: a population-based study (DIABAUD2). Diabetes Care 2001 24 239-244.
80. Edge JA, Dunger DB, Matthews DR, Gilbert JP & Smith CP. Increased overnight growth hormone concentrations in diabetic compared with normal adolescents. Journal of Clinical Endocrinology and Metabolism 1990 71 1356-1362.
81. Asplin CM, Faria AC, Carlsen EC, Vaccaro VA, Barr RE, Iranmanesh A, Lee MM, Veldhuis JD & Evans WS. Alterations in the pulsatile mode of growth hormone release in men and women with insulin-dependent diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 1989 69 239-245.
82. Batch JA & Werther GA. Changes in growth hormone concentrations during puberty in adolescents with insulin-dependent diabetes. Clinical Endocrinology 1992 36 411-416.
83. Press M, Tamborlane WV & Sherwin RS. Importance of raised growth hormone levels in mediating the metabolic derangements of diabetes. New England Journal of Medicine 1984 310 810-815.
84. Arslanian S, Heil B, Becker D & Drash AL. Sexual dimorphism in insulin sensitivity in adolescents with insulin-dependent diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 1991 72 920-926.
85. Danne T, Kordonouri O, Enders I & Weber B. Factors influencing height and weight development in children with diabetes. Results of the Berlin Retinopathy Study. Diabetes Care 1997 20 281-283.
86. Jivani SK & Rayner PH. Does control influence the growth of diabetic children? Archives of Diseases in Childhood 1973 48 109-115.
87. Ahmed ML, Connors MH, Drayer NM, Jones JS & Dunger DB. Pubertal growth in IDDM is determined by HbAlc levels, sex, and bone age. Diabetes Care 1998 21 831-835.
88. Tattersall RB & Pyke DA. Growth in diabetic children at onset of symptoms. Lancet 1973 2 1105-1109.
89. Vanelli M, de Fanti A. Adinolfi B & Ghizzoni L. Clinical data regarding the growth of diabetic children. Hormone Research 1992 37 65-69.
90. Radetti G, Paganini C, Antoniazzi F, Pasquino B, Valentini R. Gentili L & Tato L. Growth hormone-binding proteins. IGF-I and IGF-binding proteins in children and adolescents with type 1 diabetes mellitus. Hormone Research 1997 47 110-115.
91. Clayton KL, Holly JM, Carlsson LM, Jones J, Cheetham TD, Taylor AM & Dunger DB. Loss of the normal relationships between growth hormone, growth hormone-binding protein and insulin-like growth factor-I in adolescents with insulin-dependent diabetes mellitus. Clinical Endocrinology 1994 41 517-524.
92. Massa G. Dooms L, Bouillon R & Vanderschueren-Lodeweyckx M. Serum levels of growth hormone-binding protein and insulin-like growth factor I in children and adolescents with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993 36 239-243.
93. Dunger DB. Insulin and insulin-like growth factors in diabetes mellitus. Archives of Diseases in Childhood 1995 72 469-471.
94. Salerno M, Argenziano A, Di Maio S, Gasparini N, Formicola S, De Filippo G & Tenore A. Pubertal growth, sexual maturation, and final height in children with IDDM. Effects of age at onset and metabolic control. Diabetes Care 1997 20 721-724.
95. Holl RW, Grabert M, Heinze E, Sorgo W & Debatin KM. Age at onset and long-term metabolic control affect height in type-1 diabetes mellitus. European Journal of Pediatrics 1998 157 972-977.